AbbVie Inc (ABBV)

Get AbbVie Inc (ABBV) share price insights and news for better trading decisions. Stay informed with FP Markets Rwanda.

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

AbbVie Inc (ABBV) Profile

AbbVie Inc (ABBV.xnys) is a biopharmaceutical company headquartered in North Chicago, Illinois, America. AbbVie, after the separation from Abbott Laboratories, started operating as a research-based pharmaceutical manufacturer to allow markets to value the two businesses separately. The company is committed to product development in the cystic fibrosis disease area and plans to reduce emissions by 25 per cent by 2025. Abbvie employs 47,000 people in 170 countries across the globe. AbbVie Inc stock (ABBV.xnys) is listed on the New York Stock Exchange (NYSE) and had a $45.80B (USD) market capitalisation as of January 2022. The company announced the acquisition of Soliton Inc at the beginning of 2022 in order to include a proven treatment for the appearance of cellulite. AbbVie has also got approval from the Food and Drug Administration (FDA) for the RINVOQ medicine to treat adults with active psoriatic arthritis and the VUITY medicine, which is the first and only eye drop to treat presbyopia. The second one is a common and progressive eye condition that affects 128M Americans, and its treatment is now available by prescription in pharmacies nationwide.

Start Trading AbbVie Inc (ABBV) with a Market Leader Today

AbbVie Inc (ABBV) Trading FAQ

Shares represent units of ownership within a company. Shares are also known as stocks or equities. Dividend payments are common with some companies, a method of sharing company profits with shareholders. In addition to traditional share dealing, however, traders can access derivatives: trading instruments derived from the movement of an underlying share price.

Individual stock CFDs (contract for differences) fall under the umbrella of derivative products, an effective low-cost trading vehicle. While CFDs do not grant shareholder privileges, active CFD positions may receive a dividend if executed before the ex-dividend date.

Start Trading
in minutes

Get instant Updates in Telegram